Durvalumab and Anlotinib Boost Small-Cell Lung Cancer Treatment
In a groundbreaking advancement poised to reshape the therapeutic landscape for extensive-stage small-cell lung cancer (ES-SCLC), a multicenter, randomized phase ...
Tag: Immunotherapy in Small-Cell Lung Cancer
Immunotherapy Plus Chemoradiotherapy Boosts Small-Cell Lung Cancer
Immunotherapy Concurrently Administered with Chemoradiotherapy Shows Promise in Limited-Stage Small-Cell Lung Cancer Limited-stage small-cell lung cancer (LS-SCLC) has long posed ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!